Hans Prenen Selected Research

Body Weight (Weight, Body)

7/2022	Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
1/2020	Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans Prenen Research Topics

Disease

41	Neoplasms (Cancer) 07/2022 - 02/2005
27	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2009
14	Neoplasm Metastasis (Metastasis) 02/2021 - 12/2010
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2008 - 02/2005
4	Inflammation (Inflammations) 07/2022 - 08/2013
4	Adenocarcinoma 01/2021 - 10/2012
3	Disease Progression 01/2022 - 05/2019
3	Hypoxia (Hypoxemia) 01/2021 - 01/2012
3	Fatigue 01/2021 - 01/2016
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 01/2017
2	Pain (Aches) 07/2022 - 12/2017
2	Body Weight (Weight, Body) 07/2022 - 01/2020
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 05/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 12/2019
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2011
2	Barrett Esophagus (Barrett's Esophagus) 01/2021 - 10/2012
2	Fever (Fevers) 11/2020 - 01/2016
1	Cardiotoxicity 07/2022
1	Coronary Disease (Coronary Heart Disease) 07/2022
1	Myocarditis (Carditis) 07/2022
1	Cholangiocarcinoma 07/2022
1	Wasting Syndrome (Wasting Disease) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Cachexia 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Microsatellite Instability 03/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hepatitis 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2021
1	Abdominal Obesity 01/2021
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2021
1	Abdominal Pain (Pain, Abdominal) 11/2020
1	Hypertension (High Blood Pressure) 11/2020

Drug/Important Bio-Agent (IBA)

9	Monoclonal AntibodiesIBA 10/2021 - 05/2009
9	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2015
8	Bevacizumab (Avastin)FDA Link 01/2019 - 01/2009
6	ErbB Receptors (EGF Receptor)IBA 10/2021 - 05/2009
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 05/2009
6	Imatinib Mesylate (Gleevec)FDA Link 09/2008 - 02/2005
5	Phosphotransferases (Kinase)IBA 01/2019 - 03/2006
4	Tyrosine Kinase InhibitorsIBA 07/2022 - 01/2006
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
4	Panitumumab (Vectibix)FDA Link 10/2021 - 08/2014
3	Immune Checkpoint InhibitorsIBA 07/2022 - 01/2021
3	Pharmaceutical PreparationsIBA 02/2021 - 08/2013
3	Sunitinib (Sutent)FDA Link 11/2015 - 04/2006
3	Biological ProductsIBA 08/2013 - 12/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 12/2010
2	IronIBA 01/2022 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 10/2012
2	Messenger RNA (mRNA)IBA 01/2020 - 05/2019
2	regorafenibIBA 01/2019 - 01/2016
2	afliberceptIBA 01/2019 - 10/2012
2	Epidermal Growth Factor (EGF)IBA 06/2017 - 12/2011
2	MTOR InhibitorsIBA 11/2016 - 01/2009
2	AntibodiesIBA 10/2014 - 12/2010
2	Cetuximab (Erbitux)FDA Link 01/2013 - 05/2009
2	Sorafenib (BAY 43-9006)FDA Link 01/2009 - 09/2008
2	nilotinib FDA Link 09/2008 - 01/2006
2	Protein Isoforms (Isoforms)IBA 09/2008 - 04/2006
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2008 - 04/2006
1	SteroidsIBA 07/2022
1	IpilimumabIBA 07/2022
1	Prednisolone (Predate)FDA LinkGeneric 07/2022
1	TroponinIBA 07/2022
1	NivolumabIBA 07/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	sotorasibIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	NitrogenIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	budigalimabIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	rovalpituzumab tesirineIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	LY3300054IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	IDO-1 inhibitor LY3381916IBA 01/2021
1	Transaminases (Aminotransferases)IBA 11/2020
1	CytokinesIBA 09/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2020

Therapy/Procedure

27	Therapeutics 07/2022 - 05/2008
16	Drug Therapy (Chemotherapy) 10/2018 - 08/2006
4	Microspheres (Microsphere) 11/2020 - 01/2016
3	Neoadjuvant Therapy 01/2021 - 05/2019
2	Immunotherapy 03/2021 - 01/2020
2	Radiotherapy 09/2020 - 09/2015
2	Catheters 07/2020 - 06/2016
2	Precision Medicine 01/2020 - 12/2019
2	Salvage Therapy 01/2016 - 01/2013
1	Stem Cell Transplantation 01/2022
1	Chemoradiotherapy 01/2021
1	Organ Sparing Treatments 01/2021